| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |